Dr. Appelbaum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
NE Pacific St
# 1959
Seattle, WA 98195Phone+1 206-288-1000Fax+1 206-606-1025
Education & Training
Tufts University School of MedicineClass of 1972
Certifications & Licensure
WA State Medical License 1978 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemia.Corentin Orvain, Filippo Milano, Eduardo Rodríguez-Arbolí, Megan Othus, Effie W Petersdorf
Leukemia. 2024-12-12 - 5 citationsGenetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations.Hartmut Döhner, Courtney D DiNardo, Frederick R Appelbaum, Charles Craddock, Hervé Dombret
Blood. 2024-11-21 - 10 citationsAn 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.Mohamed L Sorror, Ted A Gooley, Barry E Storer, Aaron T Gerds, Mikkael A Sekeres
Blood. 2023-01-19
Abstracts/Posters
- Development and Performance of Risk Stratification Models for AML Patients Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG ReportFrederick R. Appelbaum, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Increasing Lengths of First Complete Remission with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia over the Past Four Decades: Analysis of SWOG Trial DataFrederick R. Appelbaum, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Superior Survival with Post-Remission Pediatric-Inspired Chemotherapy Compared to Myeloablative Allogeneic Hematopoietic Cell Transplantation in Adolescents and Young ...Frederick R. Appelbaum, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
